20 March 2014 Quantitative ultrasound monitoring of breast tumor response to chemotherapy by analysis of frequency-dependent attenuation and backscattered power
Author Affiliations +
Abstract
Conventional assessment of tumor response to anti-cancer therapy is based on measurements of tumor size (RECIST criteria). However, these measurements are typically a late indicator of tumor response (detectable after several weeks to a few months). There is currently no method to assess tumor response early in the course of therapy. In this study, quantitative ultrasound (QUS) methods were used to characterize the frequency-dependent attenuation and backscatter properties of treatment responding and non-responding tumors in breast cancer patients receiving neoadjuvant chemotherapy. In addition, we assessed the effects of attenuation correction of the power spectrum on the ability to differentiate between responding and non-responding tumors during the course of treatment.
© (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
H. Tadayyon, H. Tadayyon, Lakshmanan Sannachi, Lakshmanan Sannachi, G. J. Czarnota, G. J. Czarnota, } "Quantitative ultrasound monitoring of breast tumor response to chemotherapy by analysis of frequency-dependent attenuation and backscattered power", Proc. SPIE 9040, Medical Imaging 2014: Ultrasonic Imaging and Tomography, 904009 (20 March 2014); doi: 10.1117/12.2043075; https://doi.org/10.1117/12.2043075
PROCEEDINGS
8 PAGES


SHARE
Back to Top